Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma

(2018) Lucia Demkova et al.   Molecular Cancer

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines

(2018) Ewelina Dratkiewicz et al.   Oncotarget

Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation

(2017) Hiroki Yasui et al.   ONCOLOGY REPORTS

Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion

(2017) Marina Di Domenico et al.   Oncotarget

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy

(2017) Bin Li et al.   Oncotarget

The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer

(2016) Bok-Soon Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Varying effects of EGF, HGF and TGFβ on formation of invadopodia and invasiveness of melanoma cell lines of different origin

(2016) A. Makowiecka et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

(2016) Erik S. Linklater et al.   Oncotarget

A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor

(2015) Erika Kovacs et al.   Annual Review of Biochemistry

Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF)

(2015) Brittany L. Carpenter et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion

(2015) Hui-Hui Cao et al.   Molecular Cancer

Role of ErbB Receptors in Cancer Cell Migration and Invasion

(2015) Aline Appert-Collin et al.   Frontiers in Pharmacology

Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies

(2014) C. M. Lovly et al.   CLINICAL CANCER RESEARCH

ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways

(2014) Christiane D. Fichter et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathway

(2014) Alexander Gross et al.   Targeted Oncology

FAK competes for Src to promote migration against invasion in melanoma cells

(2014) K Kolli-Bouhafs et al.   Cell Death & Disease

Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model

(2013) O. Surriga et al.   MOLECULAR CANCER THERAPEUTICS

Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells

(2013) Karen L. Burger et al.   PROSTATE

The XTT Cell Proliferation Assay Applied to Cell Layers Embedded in Three-Dimensional Matrix

(2012) Lynn Huyck et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Pathological roles of invadopodia in cancer invasion and metastasis

(2012) Hideki Yamaguchi   EUROPEAN JOURNAL OF CELL BIOLOGY

Met receptor tyrosine kinase signals through a cortactin–Gab1 scaffold complex, to mediate invadopodia

(2012) Charles V. Rajadurai et al.   JOURNAL OF CELL SCIENCE

Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment

(2012) Malgorzata Sztiller-Sikorska et al.   MELANOMA RESEARCH

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

(2012) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression of the c-Met Proteins in Malignant Skin Cancers

(2011) Yoon-Jin Lee et al.   Annals of Dermatology

An EGFR-Src-Arg-Cortactin Pathway Mediates Functional Maturation of Invadopodia and Breast Cancer Cell Invasion

(2011) C. C. Mader et al.   CANCER RESEARCH

Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

(2011) H. Xu et al.   CLINICAL CANCER RESEARCH

Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin

(2011) Jian-Hong Zuo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

EGFR in melanoma: clinical significance and potential therapeutic target

(2011) Barbara Boone et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Synergistic Effects of Foretinib with HER-Targeted Agents in MET and HER1- or HER2-Coactivated Tumor Cells

(2011) L. Liu et al.   MOLECULAR CANCER THERAPEUTICS

Receptor tyrosine kinases and their activation in melanoma

(2011) David J. Easty et al.   Pigment Cell & Melanoma Research

c-MET as a potential therapeutic target and biomarker in cancer

(2011) J. Rafael Sierra et al.   Therapeutic Advances in Medical Oncology

Cytokines and Growth Factors Expressed by Human Cutaneous Melanoma

(2010) Elias G. Elias et al.   Cancers

Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells

(2009) Paolo Accornero et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors

(2009) Michalis V Karamouzis et al.   LANCET ONCOLOGY

Assembly and biological role of podosomes and invadopodia

(2008) Mario Gimona et al.   CURRENT OPINION IN CELL BIOLOGY

ErbB receptors and cell polarity: New pathways and paradigms for understanding cell migration and invasion

(2008) Michael E. Feigin et al.   EXPERIMENTAL CELL RESEARCH